REG - Royal Bank of Canada - Publication of a Prospectus

Royal Bank of CanadaAnnouncement

10/06/2022 15:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220610:nRSJ5186Oa&default-theme=true

RNS Number : 5186O  Royal Bank of Canada  10 June 2022

 

RNS ANNOUNCEMENT

 

RNS Number:

Royal Bank of Canada

June 10, 2022

 

Publication of Prospectus

 

Not for release, publication or distribution, directly or indirectly, in or
into the United States.

 

Royal Bank of Canada has agreed to issue GBP500,000,000 3.625 per cent. Senior
Notes due June 14, 2027, Series 65385 (the "Notes") pursuant to its Programme
for the Issuance of Securities (the "Programme").

 

The following document constitutes the final terms dated June 10, 2022 (the
"Final Terms") relating to the admission to trading of the Notes for purpose
of Article 8 of Regulation (EU) 2017/1129 and as it forms part of domestic law
by virtue of the European Union (Withdrawal) Act 2018 (EUWA)  and must be
read in conjunction with the Prospectus dated July 23, 2021, as supplemented
by the 1(st) Supplementary Notes Base Prospectus dated August 31, 2021, the
2(nd) Supplementary Prospectus dated January 5, 2022, the 3(rd) Supplementary
Prospectus dated February 25, 2022 and the 4(th) Supplementary Prospectus
dated May 27, 2022 relating to the Programme (together, the "Prospectus").
Full information on Royal Bank of Canada and the offer of the Notes is only
available on the basis of the combination of the Final Terms and the
Prospectus.

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus and the Final
Terms, may be addressed to and/or targeted at persons who are residents of
particular countries (specified in the Prospectus) only and is not intended
for use and should not be relied upon by any person outside these countries
and/or to whom the offer contained in the Final Terms is not addressed.
Prior to relying on the information contained in the Final Terms you must
ascertain from the Prospectus, as supplemented by these Final Terms, whether
or not you are part of the intended addressees of the information contained
therein.

 

The Notes have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act") or the securities
laws of any state of the US and are subject to US tax law requirements.
Subject to certain exceptions, the Notes may not be offered, sold or delivered
in or into the United States or to or for the account or benefit of a "US
person" (as defined in Regulation S under the Securities Act).  No public
offering of the Notes is being made in the United States.  This announcement
does not constitute an offer to sell or a solicitation to buy securities in
the United States or in any other jurisdiction where such offer or
solicitation would be unlawful.

 

Your right to access this service is conditional upon complying with the above
requirement.

 

UK MiFIR professionals / MiFID II professionals / ECPs-only / No PRIIPs or UK
PRIIPs KID - Manufacturer target market (UK MiFIR product governance and MiFID
II product governance) is eligible counterparties and professional clients
only (all distribution channels).  No PRIIPs or UK PRIIPs key information
document (KID) has been prepared as not available to retail in EEA or the UK.

 

To view the full document, please paste the following URLs into the address
bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/5186O_1-2022-6-10.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/5186O_1-2022-6-10.pdf)

 

 

 

For further information, please contact

Erin Dion

Assistant General Counsel

Royal Bank of Canada

Telephone Number:  (416) 974-4103

Fax Number:  (416) 955-2032

Email:  erin.dion@rbc.com

 

 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PDIMZGMVFGNGZZM